Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.04%84.480.9%$1037.96m
KITEKite Pharma, Inc.
0.18%179.6316.1%$788.56m
CELGCelgene Corporation
-0.48%144.241.1%$523.61m
AMGNAmgen Inc.
-0.08%186.141.1%$498.96m
BIIBBiogen Inc.
-0.29%316.581.2%$434.74m
REGNRegeneron Pharmaceuticals, Inc.
-0.35%436.632.7%$369.01m
ALNYAlnylam Pharmaceuticals, Inc
-4.14%112.1910.7%$259.10m
ALXNAlexion Pharmaceuticals, Inc.
-2.66%140.131.9%$232.10m
JUNOJuno Therapeutics, Inc.
-1.37%41.7514.6%$228.36m
INCYIncyte Corporation
-0.64%108.992.6%$223.61m
VRTXVertex Pharmaceuticals Incorporated
0.24%149.451.9%$216.83m
ILMNIllumina, Inc.
-1.18%199.003.5%$163.10m
BLUEBluebird Bio, Inc.
-2.30%127.5019.3%$145.94m
BMRNBioMarin Pharmaceutical Inc.
-1.24%93.224.4%$140.71m
CLVSClovis Oncology, Inc.
-3.07%73.6318.0%$133.35m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address hematology indications. It offers next generation hemostasis programs and anti-complement assets. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.